# Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction

> **NCT03950115** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 81 (actual)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** Intense Pulsed Light (IPL)

## Key facts

- **NCT ID:** NCT03950115
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-18
- **Primary completion:** 2020-02-18
- **Final completion:** 2020-04-10
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950115, "Effects and Prognostic Factors of Intensive Pulse Light Treatment for Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03950115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*